Publications by authors named "Amir Mehdizadeh-Shrifi"
Aims: Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI-related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI-related adverse events. Additionally, whether incident irM portends worse long-term CV outcomes remains unclear.
View Article and Find Full Text PDFBirth in the Operating Room for Immediate Cardiac Surgery: A Rare but Effective Strategy.
World J Pediatr Congenit Heart Surg
November 2024
Article Synopsis
- Significant advancements in fetal cardiac imaging have allowed for earlier diagnosis of complex congenital heart disease (CHD) in infants at high risk for postnatal issues, prompting a new strategy for immediate surgical intervention.
- Between 2012 and 2023, eight prenatally diagnosed CHD infants were delivered in an operating room next to a cardiac OR, with six undergoing surgery on their birth day for conditions like obstructed total anomalous pulmonary venous return (TAPVR).
- The overall five-year postoperative survival rate for these infants was 88%, indicating that this interdisciplinary approach to birth and immediate care may lead to better outcomes compared to historical data.
Data on concomitant cardiac surgery (CCS) performed during pediatric lung transplantation (LTx) is limited. Therefore, we conducted a multi-institutional analysis to identify the incidence and outcomes of CCS in pediatric (< 18 years) LTx recipients by merging data (2004-2023) from the United Network for Organ Sharing (UNOS) and Pediatric Health Information System (PHIS) databases. Of the total of 596 pediatric LTx recipients, 87 (15%) underwent CCS.
View Article and Find Full Text PDFObjectives: To evaluate how the certification of specialised Oncology Centres in Germany affects the relative survival of patients with colorectal cancer (CRC) by means of national and international comparison.
Methods: Between 2007 and 2013, 675 patients with colorectal cancer, treated at the Hildesheim Hospital, an academic teaching hospital of the Hannover Medical School (MHH), were included. A follow-up of the entire patient group was performed until 2014.